Professur für Molekulare Mechanismen der Organfibrose

RELATIONSHIP BETWEEN ANTI-MDA5 ANTIBODIES AND CANCER: RETROSPECTIVE ANALYSIS OF AN INTERNATIONAL AND MULTIDISCIPLINARY COHORT (2019) De Stefano L, Castaneda S, De Langhe E, Distler J, Knitza J, Cavazzana I, Meyer A, et al. Conference contribution POTENTIAL CELLULAR AND MOLECULAR TARGETS (2019) Distler J Conference contribution PU.1 INHIBITOR DB1976 CONTROLS FIBROBLAST POLARIZATION IN SYSTEMIC SCLEROSISAND LEADS TO REGRESSION OF FIBROSIS IN DIFFERENT MODELS OF ORGAN FIBROSIS (2019) Wohlfahrt T, Rauber S, Luber M, Soare A, Weber S, Matei AE, Chen CW, et al. Conference contribution FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY (2019) Renoux F, Stellato M, Vogetseder A, Huang R, Subramaniam A, Blyszczuk P, Distler J, et al. Conference contribution PROFIBROTIC LNCRNA H19X: UNRAVELLING THE EFFECTS ON CHROMATIN REMODELING IN SYSTEMIC SCLEROSIS FIBROBLASTS (2019) Pachera E, Assassi S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort (2019) Wu W, Jordan S, Graf N, Pena JDO, Curram J, Allanore Y, Matucci-Cerinic M, et al. Journal article The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target (2019) Henderson J, Distler J, O'Reilly S Journal article, Review article Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation (2019) Heim C, Mauer J, Kuckhahn A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM Conference contribution FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (2019) Wollin L, Distler J, Redente E, Riches D, Stowasser S, Schlenker-Herceg R Conference contribution Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts (2019) Harrach S, Barz V, Pap T, Pavenstaedt H, Schlatter E, Edemir B, Distler J, et al. Journal article